Clinical Study

Prevalence of Epithelial Ovarian Cancer Stem Cells Correlates with Recurrence in Early-Stage Ovarian Cancer

Table 3

Multivariate analyses of progression-free survival in 117 ovarian cancer patients.

Clinicopathological characteristicsB regression coefficientStandard Error (B)Hazard ratio95% CI (Hazard ratio) value*

Age−0.0250.0140.980.95–1.000.083
FIGO stage
 I/II1.00
 III/IV1.8140.5026.132.29–16.40.0003
Grade
 11.00
 20.7500.7782.120.46–9.730.34
 30.6170.7691.850.41–8.360.42
Residual tumor
 ≤1 cm1.00
 >  cm0.8580.2772.350.83–2.300.002
% E O C stem cells
 <20% CD44 Cells1.00
 >20% CD44 Cells0.8930.4162.441.08–5.520.032

*Cox regression model.